CAP-18 Antibodies

Santa Cruz Biotechnology offers a broad range of CAP-18 monoclonal antibodies for advanced research in immunology and related fields. CAP-18 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CAP-18, also known as cathelicidin antimicrobial peptide, plays a crucial role in the innate immune response, exhibiting antimicrobial properties against a wide range of pathogens. CAP-18 is actively involved in modulating inflammation and promoting wound healing, making it an important target for studies related to infection and immune disorders. Understanding CAP-18 function can provide insights into therapeutic strategies for various diseases. Research focused on CAP-18 continues to reveal new aspects of immune system regulation and host defense mechanisms. Investigating CAP-18's role in different physiological processes helps advance our understanding of immune responses and potential therapeutic applications. The high-quality monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to conduct precise investigations and make meaningful contributions to biomedical science.